Dr. Folefac is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6196Fax+1 614-293-0073
Summary
- Edmund Folefac, MD, is an oncology specialist based in Columbus, OH, currently serving as an Associate Professor at Ohio State University Wexner Medical Center since 2021 where he completed a fellowship in clinical bioethics. He completed his fellowship in Hematology, Medical Oncology and geriatrics at Boston University Medical Center in 2014 where he also completed a Master of science in clinical investigation and residency in Internal Medicine at MGH-Brigham Northshore in 2007, following his medical education at Obafemi Awolowo College of Health Sciences. Dr. Folefac has co-authored several research publications, including studies on kidney and prostate cancer, with notable works published in journals such as the British Journal of Cancer, Frontiers in oncology, molecular cancer therapeutics and Journal for Immunotherapy of Cancer. His research has been acknowledged in scientific communities, with multiple citations for his studies.
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Salem HospitalResidency, Internal Medicine, 2004 - 2007
Obafemi Awolowo College of Health Sciences, Ogun State UniversityClass of 2001
Certifications & Licensure
OH State Medical License 2017 - 2027
VT State Medical License 2014 - 2018
MA State Medical License 2006 - 2017
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsAssociations of dietary patterns with kidney cancer risk, kidney cancer-specific mortality and all-cause mortality among postmenopausal women.Qi Jin, Jinesh Gheeya, Sushma Nepal, Ni Shi, Edmund Folefac
British Journal of Cancer. 2023-12-01 - 16 citationsA Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE).Elizabeth Pan, Wanling Xie, Archana Ajmera, Arlene Araneta, Christina Jamieson
Molecular Cancer Therapeutics. 2023-04-03 - Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER d...Shihua Wang, Ming Yin, Peng Wang, Edmund Folefac, J Paul Monk
Frontiers in Oncology. 2023-01-01
Press Mentions
Lucien Alexandre, MD, PhD, an Interventional Pain Management Physician with Pain Care Specialists of FloridaDecember 3rd, 2021
As Routine Prostate Cancer Screenings Fall, Advanced Cases RiseMay 20th, 2020
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
